Abatacept Biosimilar - Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb - Research Grade
Source
DrugBank DB01281
Species
Human
Molecular weight
92kDa
Purity
>85%
Buffer
PBS pH7.5
Delivery condition
Blue ice (+4°C)
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
4°C for short term; -20°C for long term
Brand
ProteoGenix
Aliases /Synonyms
Abatacept,Abatacept,CTLA-4 extracellular domain linked to IgG1 Fc,anti-CTLA-4 extracellular domain linked to IgG1 Fc
Reference
PX-TA1020
Note
For research use only. Not suitable for clinical or therapeutic use.
Isotype
hG1-Fc
Clonality
Monoclonal Antibody
Description of Abatacept Biosimilar - Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb - Research Grade
General information about Abatacept
Abatacept est une protéine de fusion composée du domaine extracellulaire de l’antigène 4 cytotoxique humain associé au lymphocyte T (CTLA-4) lié à une partie Fc modifiée d’immunoglobuline humaine (IgG1) qui inhibe le signal de co-stimulation CD80/86 nécessaire à l’activation des lymphocytes T exprimant le CD28. This product is for research use only.
Reviews
There are no reviews yet.